Axsome Therapeutics
AXSM
AXSM
35 hedge funds and large institutions have $10.8M invested in Axsome Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.63% less ownership
Funds ownership: 13.46% → 12.84% (-0.63%)
12% less capital invested
Capital invested by funds: $12.2M → $10.8M (-$1.4M)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Holders
35
Holding in Top 10
1
Calls
$284K
Puts
$63K
Top Buyers
| 1 | +$1.02M | |
| 2 | +$871K | |
| 3 | +$705K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$322K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$208K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$660K | |
| 3 | -$415K | |
| 4 |
JP Morgan Chase
New York
|
-$140K |
| 5 |
SCM
Sio Capital Management
New York
|
-$101K |